BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34565720)

  • 1. Abnormal m6A modification in non-alcoholic fatty liver disease.
    Li Z; Qi J; Liu H; Tang Y; Liu J; Sun C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):785-792. PubMed ID: 34565720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
    Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
    Front Immunol; 2021; 12():769204. PubMed ID: 34880865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
    Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J
    Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.
    Luo Y; Zhang Z; Xiang L; Zhou B; Wang X; Lin Y; Ding X; Liu F; Lu Y; Peng Y
    Front Endocrinol (Lausanne); 2021; 12():780617. PubMed ID: 34950107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL16-mediated translation of
    Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J
    PeerJ; 2022; 10():e14379. PubMed ID: 36518278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
    Chen Y; Huang H; Xu C; Yu C; Li Y
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.
    Sun C; Liu X; Yi Z; Xiao X; Yang M; Hu G; Liu H; Liao L; Huang F
    IUBMB Life; 2015 Nov; 67(11):847-52. PubMed ID: 26472541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
    Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
    Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of m6A modification lncRNAs in high glucose and TNF-α induced human umbilical vein endothelial cells.
    Shan L; Guo M; Dai Y; Wei L; Zhang W; Gao J
    Medicine (Baltimore); 2023 Mar; 102(10):e33133. PubMed ID: 36897718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Expressions and m6A Methylation Modification Patterns of mRNAs and lncRNAs in a Spinal Cord Injury Rat Model.
    Liu X; Li Z; Tong J; Wu F; Jin H; Liu K
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38907070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
    Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
    Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
    Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N
    Peng Y; Wang Z; Li B; Tan W; Zou J; Li Y; Yoshida S; Zhou Y
    Exp Eye Res; 2022 Jul; 220():109114. PubMed ID: 35584758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic allergic asthma alters m6A epitranscriptomic tagging of mRNAs and lncRNAs in the lung.
    Ni X; Li X; Hu B; Wang L
    Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36250525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression profile of long non-coding RNA in non-alcoholic fatty liver disease].
    Sun C; Huang F; Yan W; Liu H; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):741-748. PubMed ID: 28844995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
    Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
    Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
    Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
    Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
    Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
    Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of lncRNAs N
    Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.